Patents by Inventor Ethan Lee Zimbra

Ethan Lee Zimbra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11173237
    Abstract: A spectroscopic detection system includes a sensor configured to reflect light of a first wavelength associated with a presence of a reference substance on the sensor and configured to reflect light of a second wavelength associated with a presence of a monitored substance on the sensor, wherein the monitored substance flows to the sensor from a circulating fluid. The spectroscopic detection system further includes a detector that has first and second channels for respectively receiving the light of the first and second wavelengths reflected from the sensor and one or more processors in electrical communication with the detector and configured to identify an excess condition of the monitored substance with respect to the circulating fluid based on a ratio of a second amount of the light of the second wavelength received at the detector to a first amount of the light of the first wavelength received at the detector.
    Type: Grant
    Filed: July 31, 2020
    Date of Patent: November 16, 2021
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Harshavardhana Reddy Mallipalli, Philip Scott James, Ethan Lee Zimbra, Kerissa Adams, Troy Dayton, Jon F. Moss
  • Publication number: 20200405937
    Abstract: A spectroscopic detection system includes a sensor configured to reflect light of a first wavelength associated with a presence of a reference substance on the sensor and configured to reflect light of a second wavelength associated with a presence of a monitored substance on the sensor, wherein the monitored substance flows to the sensor from a circulating fluid. The spectroscopic detection system further includes a detector that has first and second channels for respectively receiving the light of the first and second wavelengths reflected from the sensor and one or more processors in electrical communication with the detector and configured to identify an excess condition of the monitored substance with respect to the circulating fluid based on a ratio of a second amount of the light of the second wavelength received at the detector to a first amount of the light of the first wavelength received at the detector.
    Type: Application
    Filed: July 31, 2020
    Publication date: December 31, 2020
    Inventors: Harshavardhana Reddy Mallipalli, Philip Scott James, Ethan Lee Zimbra, Kerissa Adams, Troy Dayton, Jon F. Moss
  • Patent number: 10765793
    Abstract: A spectroscopic detection system includes a sensor configured to reflect light of a first wavelength associated with a presence of a reference substance on the sensor and configured to reflect light of a second wavelength associated with a presence of a monitored substance on the sensor, wherein the monitored substance flows to the sensor from a circulating fluid. The spectroscopic detection system further includes a detector that has first and second channels for respectively receiving the light of the first and second wavelengths reflected from the sensor and one or more processors in electrical communication with the detector and configured to identify an excess condition of the monitored substance with respect to the circulating fluid based on a ratio of a second amount of the light of the second wavelength received at the detector to a first amount of the light of the first wavelength received at the detector.
    Type: Grant
    Filed: June 27, 2019
    Date of Patent: September 8, 2020
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Harshavardhana Reddy Mallipalli, Philip Scott James, Ethan Lee Zimbra, Kerissa Adams, Troy Dayton, Jon F. Moss